Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-02 · accession 0001415889-24-010324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-04 | 2024-04-02 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | A - Grant | $0.00 | +37.5K | 171.0K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-04-02 | A | A | 37,500 | $0.00 | 171,034 | D | — | — |